By Daree Allen Nieves  |  Last updated: June 13, 2026  |  Ghostwriting for healthtech

Healthtech companies tend to ask about ghostwriting in one of two ways. Either someone says, “We need a newsletter,” and what they actually need is an email sequence that teaches their users how to use a feature. Or they say, “Our CEO needs to post more on LinkedIn,” and the real problem is that their clinicians don’t understand why the platform exists. The content type gets named before the problem is understood.

This page breaks down three types of ghostwritten content I offer — educational email content (EEC), newsletter ghostwriting, and thought leadership — and gives you a clear way to tell which one your company actually needs right now.

What is educational email content (EEC) for healthtech companies?

Educational email content is a structured sequence of emails written to teach a specific audience what they need to know to take a specific action. It’s not a marketing funnel. The goal isn’t to persuade someone to buy — it’s to ensure that someone who is already in your product, your care program, or your clinical workflow actually understands it well enough to use it.

Healthtech companies have three primary EEC use cases:

• SaaS onboarding (1B) — for new platform users who need to activate and build a habit with the product. These sequences close the distance between account creation and meaningful use.
• Provider and clinician education (1C) — for clinical staff who need to understand a new workflow, tool, or protocol. Clinicians are skeptical of things that add steps to their day. This content makes the case for change in clinical terms.
• Patient and caregiver education (1D) — for patients or caregivers who received access to a digital health tool but didn’t receive the education they need to trust or use it. These sequences explain what the platform does, answer the questions patients actually have, and build confidence before they’re expected to engage on their own.

EEC is a project-based engagement. You come in with a problem — my users aren’t activating, my clinicians aren’t logging in, my patients aren’t completing their care plan tasks — and EEC is the content built to address it directly.

What is newsletter ghostwriting for healthtech?

A ghostwritten newsletter is a recurring publication, usually weekly or biweekly, written under a company name or a named executive’s byline. It’s different from a company newsletter in an important way: it has an editorial point of view. The reader isn’t there for product updates — they’re there because the publication consistently gives them something worth reading.

For healthtech companies, newsletter ghostwriting typically serves one of two audiences:

• Practitioners and clinical buyers — a clinical-audience newsletter that keeps your brand relevant and trusted in a space where buying cycles are long and relationships matter
• Industry peers and ecosystem partners — a market-facing newsletter that builds a community around a point of view your company owns

Newsletter ghostwriting requires editorial consistency that most internal marketing teams struggle to sustain alongside everything else. The commitment is the point: showing up every week, with a perspective, over time is what builds the subscriber relationship. Ghostwriting handles the writing so the cadence doesn’t slip.

“60% of decision-makers say thought leadership is more trustworthy than traditional marketing materials — but 71% say fewer than half of what they read offers genuine insight.” — 2024 Edelman-LinkedIn B2B Thought Leadership Impact Report

The same logic applies to newsletters. Consistency builds trust. Trust is what actually influences a buying decision in a category where the stakes — clinical outcomes, patient safety, regulatory compliance — are high enough that buyers can’t afford to make a mistake.

What is thought leadership ghostwriting for healthtech?

Thought leadership ghostwriting means writing LinkedIn posts, long-form articles, or bylined pieces in an executive’s voice. The goal is to make a founder, CMO, or clinical director visible in the conversations their buyers are having — before those buyers are in the pipeline.

In healthtech, buyers do a lot of research before they ever fill out a demo form. They’re reading industry coverage, following voices they trust on LinkedIn, and forming opinions about which companies understand their problems. If your executives aren’t part of those conversations, they’re not part of the consideration set.

“75% of prospective buyers say thought leadership content caused them to research a vendor they weren’t previously considering.” — 2024 Edelman-LinkedIn B2B Thought Leadership Impact Report

What distinguishes thought leadership ghostwriting from content marketing is the subject. Content marketing promotes your product category. Thought leadership promotes a person’s perspective. When a VP of Operations at a health system follows your CMO’s LinkedIn feed because they find her takes on interoperability useful, that’s thought leadership working. Your product isn’t mentioned in every post. But when that VP goes into a buying cycle six months later, they already know who you are.

Which type of content does a Series A healthtech company need?

Series A companies typically have a product in the market and early customers. The problem they’re most likely to bring to a ghostwriter isn’t awareness — it’s adoption. Users are signing up but not activating. Clinicians are credentialed but not logging in. Patients are enrolled but not engaging.

Those are EEC problems. The highest-priority content investment for most Series A healthtech companies is a structured educational email sequence written for the people already inside the product or care workflow.

Thought leadership isn’t wrong at Series A — it can support deals already in progress and help the founding team build a network. But if the adoption floor isn’t solid, thought leadership compounds on a foundation that’s still cracking. Fix the activation problem first.

Which type of content does a Series B healthtech company need?

Series B is usually the point where both adoption and awareness start to matter at the same time. The customer base is growing, which means EEC remains important as you onboard more users, clinicians, and patients. Simultaneously, deals are getting larger and buyers are more sophisticated — which means the executive team’s credibility starts to influence outcomes in ways it didn’t at Series A.

Series B companies often need EEC and thought leadership running in parallel. They serve different audiences with different content and don’t create strategic conflict. The constraint is usually budget and internal bandwidth, not overlap.

Newsletter ghostwriting becomes worth considering at Series B if you have an established audience to publish to and the organizational discipline to treat the newsletter as a real editorial commitment.

What type of content helps with clinician adoption in healthcare SaaS?

Clinicians are a specific and demanding audience for educational content. They’re skeptical of tools that add steps to an already compressed workflow. They want to understand the clinical rationale before they’ll commit to changing a habit. And they almost never read the same long onboarding documentation that a general SaaS user would ignore.

Provider and clinician education content (EEC 1C) is written specifically for this audience. It doesn’t read like a product manual. It reads like a colleague explaining why a workflow change is worth the friction — in clinical terms, with enough specificity to be credible, and with a clear picture of what looks different once it becomes a habit.

The elements that matter for this audience specifically:

• A clear “why this matters clinically” before any “how to use it” instruction
• Patient outcome framing — what does this change for the patients they’re responsible for?
• Time-realistic expectations — what does this actually take, measured in minutes per interaction, not just “easy to use”
• Answers to the objections they already have before they ask them

What type of content helps with patient engagement in a digital health platform?

Patient and caregiver education content (EEC 1D) addresses a specific problem: the distance between enrollment and consistent engagement. Patients and caregivers often receive access to a digital health tool — an app, a remote monitoring device, a care management portal — without receiving the education they need to understand it, trust it, or use it on their own.

This content is different from clinical education in register and vocabulary. Patients aren’t reading for clinical rationale. They’re asking: What is this? Why do I need it? What happens if I don’t use it? Is my information safe? Will this replace my doctor?

EEC 1D answers those questions in plain language, in a sequence that mirrors the real pace of a new patient getting comfortable with something unfamiliar. It doesn’t assume health literacy or prior experience with digital health tools. It meets the patient where they are.

Can a healthtech company run EEC and thought leadership at the same time?

Yes — and for Series A and B companies, this is common. EEC and thought leadership address different audiences at different points in the relationship with your company. EEC addresses the people already inside your product or care workflow. Thought leadership addresses the buyers and decision-makers who aren’t in your pipeline yet.

They don’t compete strategically, and the content doesn’t overlap. A patient education email sequence and a CEO’s LinkedIn series on value-based care serve entirely different people with entirely different goals. The only real constraint is whether you have the budget to run both well at the same time.

For companies choosing between the two: start with EEC if you have an active adoption problem. Start with thought leadership if you’re preparing for a fundraise or trying to break into a new market segment where your executives aren’t known yet.

How to decide: a quick reference

If you’ve read through the sections above and you’re still deciding, here’s the short version:

Choose EEC if you can name a specific audience (users, clinicians, or patients) who need to understand something well enough to take a specific action. The content has a defined scope, a behavioral goal, and a beginning and end. It’s the right investment when the adoption problem is more urgent than the awareness problem.

Choose newsletter ghostwriting if you already have an audience worth publishing to — and the organizational consistency to treat a recurring publication as a real editorial commitment. A newsletter that goes quiet after two months is worse than no newsletter. The commitment is the point.

Choose thought leadership if your buyers are already doing research before they ever fill out a demo form, and your executive team is invisible in those conversations. The timeline is longer than most marketing teams plan for. The payoff is getting on the shortlist before you were ever formally introduced.

These aren’t mutually exclusive — and for Series A and B companies, running EEC and thought leadership in parallel is common. The audiences don’t overlap. The content doesn’t conflict. The only real constraint is whether you have the budget to do both well.

Additional resources

A few sources referenced in this page, along with research on content strategy and B2B buying behavior in healthtech:

• 2024 Edelman-LinkedIn B2B Thought Leadership Impact Report
• AMA Digital Health Study — physician adoption patterns for digital tools
• Health Affairs: Patient Digital Engagement and Health Outcomes
• HIMSS State of Healthcare Report
• Gartner: The B2B Buying Journey — how committee buying affects content strategy
• HBR: When B2B Buyers Want Thought Leadership
• CMS: Patient Engagement Strategies
• NIH: Health Literacy and Patient Education Effectiveness